Predominant distal muscle involvement in spinal muscular atrophy
Claudia Brogna(Università Campus Bio-Medico), Eugenio Mercuri(Università Cattolica del Sacro Cuore), Rita De Sanctis(Humanitas University), Claudia Cinnante(IRCCS Istituto Auxologico Italiano), Tommaso Tartaglione, Tommaso Verdolotti(Agostino Gemelli University Polyclinic), Maria Carmela Pera(Università Cattolica del Sacro Cuore), Marika Pane(Università Cattolica del Sacro Cuore), Luana Ficociello(Agostino Gemelli University Polyclinic), Lara Cristiano(Università Cattolica del Sacro Cuore), Anna Pichiecchio(University of Pavia), Laura Antonaci, Cesare Colosimo(Agostino Gemelli University Polyclinic)
Cited by 4
Related Papers
Longitudinal effect of eteplirsen versus historical control on ambulation in <scp>D</scp> uchenne muscular dystrophy
|Annals of Neurology|2015|502
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
|The Lancet Oncology|2017|493
The EU-AIMS Longitudinal European Autism Project (LEAP): design and methodologies to identify and validate stratification biomarkers for autism spectrum disorders
|Molecular Autism|2017|315
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial
|The Lancet Neurology|2021|260
The EU-AIMS Longitudinal European Autism Project (LEAP): clinical characterisation
|Molecular Autism|2017|201